[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE425605B - Forfarande for framstellning av 6-oxo-7-substituerade-och 7,7-disubstituerade-6h-indeno-(5,4-b)furan-karboxylsyror - Google Patents

Forfarande for framstellning av 6-oxo-7-substituerade-och 7,7-disubstituerade-6h-indeno-(5,4-b)furan-karboxylsyror

Info

Publication number
SE425605B
SE425605B SE7601422A SE7601422A SE425605B SE 425605 B SE425605 B SE 425605B SE 7601422 A SE7601422 A SE 7601422A SE 7601422 A SE7601422 A SE 7601422A SE 425605 B SE425605 B SE 425605B
Authority
SE
Sweden
Prior art keywords
indeno
disubstituted
furan
oxo
substituted
Prior art date
Application number
SE7601422A
Other languages
English (en)
Other versions
SE7601422L (sv
Inventor
Jr E J Cragoe
Jr O W Woltersdorf
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7601422L publication Critical patent/SE7601422L/sv
Publication of SE425605B publication Critical patent/SE425605B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7601422A 1975-02-24 1976-02-10 Forfarande for framstellning av 6-oxo-7-substituerade-och 7,7-disubstituerade-6h-indeno-(5,4-b)furan-karboxylsyror SE425605B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/552,402 US3984552A (en) 1975-02-24 1975-02-24 6-Oxo-7-substituted and 7,7-disubstituted-6H-indeno-[5,4-b]furan (and thiophene) carboxylic acids

Publications (2)

Publication Number Publication Date
SE7601422L SE7601422L (sv) 1976-08-25
SE425605B true SE425605B (sv) 1982-10-18

Family

ID=24205173

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7601422A SE425605B (sv) 1975-02-24 1976-02-10 Forfarande for framstellning av 6-oxo-7-substituerade-och 7,7-disubstituerade-6h-indeno-(5,4-b)furan-karboxylsyror

Country Status (15)

Country Link
US (1) US3984552A (sv)
JP (1) JPS6154794B2 (sv)
AU (1) AU500514B2 (sv)
BE (1) BE838828A (sv)
CA (1) CA1072972A (sv)
CH (1) CH617689A5 (sv)
DE (1) DE2607305C2 (sv)
DK (1) DK143339C (sv)
ES (1) ES445380A1 (sv)
FR (1) FR2301246A1 (sv)
GB (1) GB1497382A (sv)
HU (1) HU177120B (sv)
NL (1) NL7601295A (sv)
SE (1) SE425605B (sv)
ZA (1) ZA761046B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394385A (en) * 1980-11-21 1983-07-19 Merck & Co., Inc. Treatment of gray matter edema
US6890363B1 (en) * 1999-05-24 2005-05-10 Showa Denko K.K. Solid electrolytic capacitor and method for producing the same
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6858614B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
CA2838703C (en) 2011-06-16 2017-12-19 Korea Research Institute Of Chemical Technology Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
US9790197B2 (en) 2012-12-14 2017-10-17 Katholieke Universiteit Leuven K.U. Leuven R & D Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
JP6392241B2 (ja) 2012-12-17 2018-09-19 パリオン・サイエンシィズ・インコーポレーテッド ３，５−ジアミノ−６−クロロ−ｎ−（ｎ−（４−フェニルブチル）カルバムイミドイル）ピラジン−２−カルボキサミド化合物
DK2931713T3 (en) 2012-12-17 2017-01-30 Parion Sciences Inc CHLORPYRAZINE CARBOXAMIDE DERIVATIVES USED FOR THE TREATMENT OF DISEASES BENEFITED BY INDEPENDENT MOSPHEREWIN
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
TWI832045B (zh) 2020-04-20 2024-02-11 瑞士商諾華公司 抗病毒性1,3-二氧代茚化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931239A (en) * 1974-04-03 1976-01-06 Merck & Co., Inc. 6-Oxo-7-substituted-6H-indeno-[5,4-b]furan(and thiophene)-carboxylic acids

Also Published As

Publication number Publication date
DK56076A (da) 1976-08-25
NL7601295A (nl) 1976-08-26
CA1072972A (en) 1980-03-04
CH617689A5 (sv) 1980-06-13
AU500514B2 (en) 1979-05-24
ZA761046B (en) 1977-03-30
HU177120B (en) 1981-07-28
DE2607305C2 (de) 1987-04-30
SE7601422L (sv) 1976-08-25
DK143339C (da) 1981-12-07
DK143339B (da) 1981-08-10
AU1117976A (en) 1977-08-25
DE2607305A1 (de) 1976-09-02
JPS6154794B2 (sv) 1986-11-25
FR2301246A1 (fr) 1976-09-17
BE838828A (fr) 1976-08-23
FR2301246B1 (sv) 1980-06-20
ES445380A1 (es) 1977-10-01
US3984552A (en) 1976-10-05
JPS51110558A (sv) 1976-09-30
GB1497382A (en) 1978-01-12

Similar Documents

Publication Publication Date Title
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
SE434049B (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
RO69516A (ro) Procedeu pentru prepararea unor copolimeri grefati
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
ZA764080B (en) 2,3-dihydro-6,7-disubstituted-5-acyl benzofuran-2-carboxilic acids
RO75777A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazolin-3-one
SE425605B (sv) Forfarande for framstellning av 6-oxo-7-substituerade-och 7,7-disubstituerade-6h-indeno-(5,4-b)furan-karboxylsyror
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE423025B (sv) Forfarande for framstellning av proteinfilameter
SE431205B (sv) Forfarande for framstellning av estrar av 3-aminometylen-6,7-dimetoxi-2-metyl-4-oxo-1,2,3,4-tetrahydro-1-kinolinkarboxylsyra
SE7606890L (sv) Forfarande for framstellning av polyacetovinyldispersioner
IT1065800B (it) Procedimento per preparare trimetil-3,5,5 cicloesen-2 dione-1,4
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
RO70739A (ro) Procedeu pentru prepararea unor s-triazol(3,4-b)-benzotiazolilor
SE426067B (sv) Forfarande for framstellning av 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso (b,d) pyraner och -pyranoner
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE7600321L (sv) Forfarande for framstellning av 6,11-dihydro-11-oxodibens(b,e)oxepinalkansyror
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE7609130L (sv) Forfarande for framstellning av tradlacksdispersioner
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE415175B (sv) Forfarande for framstellning av klorcyan

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7601422-4

Effective date: 19900131

Format of ref document f/p: F